Surugadai Nihon University Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00287768
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Surugadai Nihon University Hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

aflibercept (zaltrap) (1 trial)

Drugs in Phase 3 Trials (6)

docetaxel (taxotere) (1 trial)

gimeracil (2 trials)

irinotecan (Camptosar) (1 trial)

oteracil (2 trials)

s-1 (2 trials)

tegafur (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Macular Degeneration (Phase 4)

Stomach Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 7